Mariëtte van der Velden-Roesink
Director/Board Member at Allero Therapeutics BV
Network origin in Mariëtte van der Velden-Roesink first degree
Entity | Entity type | Industry | |
---|---|---|---|
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance Brabantse Ontwikkelings Maatschappij Holding BV (BOM) is an industrial and economic development agency headquarterd in Tilburg in the southern Netherlands. Established in 1983, BOM is funded and financed by the Dutch State and the Province of Noord-Brabant. The firm offers a range of services designed to create, develop, maintain and improve the industrial structure of the region through four core activities: venture capital, foreign investment, new business and industrial parks. In particular BOM manages the Technostartersfonds, also known as the TechnoStars funds, which are regional venture capital investment vehicles based in Eindhoven. The investors are primarily institutions and high-net worth private individuals.
45
| Private Company | Investment Managers | 45 |
Allero Therapeutics BV
Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mariëtte van der Velden-Roesink via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
University of Tilburg | College/University | Graduate Degree Graduate Degree | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
Travis Road Services Netherlands BV
Travis Road Services Netherlands BV Packaged SoftwareTechnology Services Travis Road Services Netherlands BV engages in the development of booking platform for fleet owners. It offers road services, such as truck washing, tank cleaning, parking, and reparations. The company was founded by Dennis van Veggel in 2010 and is headquartered in Tilburg, the Netherlands. | Packaged Software | Chief Operating Officer | |
CESSATECH A/S | Pharmaceuticals: Major | Director/Board Member | |
ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genau & More A/S | Director/Board Member | ||
A-apoteket FMBA
A-apoteket FMBA Drugstore ChainsRetail Trade A-apoteket FMBA is a chain of pharmacies with over 90 locations and more than 200 pharmacy branches and sales throughout Denmark. A-apoteket is based in Hørsholm, DK, and their employees include a manager, sales director, CFO, chain consultants, assortment coordinators, campaign advertising manager, art director, education and event coordinator, and e-commerce and digital marketing manager. The Danish company offers both physical stores and online shopping at apoteket-online.dk, where customers can shop directly with their local pharmacy. The private company's board consists of eight pharmacists, and their chain office can be contacted at info @ a-apoteket.dk or phone 7020 7825. | Drugstore Chains | Director/Board Member | |
Ten Management BV
Ten Management BV Investment ManagersFinance Ten Management BV (TM) is an independent private equity investment firm located in Hertogenbosch, The Netherlands. Established in 2002, TM specializes in recovery management and acts as interim managers for distressed firms. They provide a combination of capital, as well as management, financial and legal expertise. TM is the fund investment manager of TransEquity Network. | Investment Managers | Private Equity Investor | |
Venvest Participaties BV
Venvest Participaties BV Investment ManagersFinance Venvest Participaties BV is an independent private equity firm with its headquarters in Oisterwijk, the Netherlands. It was founded in 2016. | Investment Managers | Founder | |
Graduate School of Immunology | College/University | Director/Board Member | |
STALLERGENES | Pharmaceuticals: Major | Corporate Officer/Principal | |
Newion Partners BV
Newion Partners BV Investment ManagersFinance Newion Partners BV (Newion) is a private equity firm located in Netherlands. The firm was founded in 2000 by Patrick Polak and Jaap van Barneveld. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Regionale Ontwikkelingsmaatschappij InnovationQuarter BV
Regionale Ontwikkelingsmaatschappij InnovationQuarter BV Investment ManagersFinance Regionale Ontwikkelingsmaatschappij InnovationQuarter BV (Innovation Quarter) is an independent venture capital firm headquartered in The Hague, the Netherlands. The firm was founded in 2013. | Investment Managers | Private Equity Analyst | |
Swanbridge Capital Management BV
Swanbridge Capital Management BV Investment ManagersFinance Swanbridge Capital Management is a venture capital firm, headquartered in Netherland. The frim founded in 2016 by Van Herk Investments, the Erasmus Medical Center and the City of Rotterdam. | Investment Managers | Private Equity Investor | |
Muna Therapeutics ApS
Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Private Equity Investor | |
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Consultant / Advisor | |
Koala Life Sciences BV | Founder | ||
Vrije Universiteit Amsterdam | College/University | Doctorate Degree | |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Sairopa B V
Sairopa B V MiscellaneousMiscellaneous Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company. | Miscellaneous | Director/Board Member | |
QAtor A/S
QAtor A/S Packaged SoftwareTechnology Services QAtor A/S develops automated and web-based electronic compliance management solutions for quality assurance management. It develops tool that automates business processes and integrate them with applications. The firm assists life science companies with comprehensive documentation and compliance management solutions for governmental agencies. The company was founded by Tim Kehling Pedersen on July 1, 2005 and is headquartered in Bagsværd, Denmark. | Packaged Software | Chairman | |
HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Stichting Wij zijn JONG | Investment Trusts/Mutual Funds | Director/Board Member | |
MENDUS AB | Biotechnology | Director/Board Member | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
IDOGEN AB (PUBL) | Biotechnology | Sales & Marketing | |
ECTIN RESEARCH AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
Glazer Consulting Holding ApS | Chief Tech/Sci/R&D Officer | ||
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark. | Biotechnology | Chief Tech/Sci/R&D Officer | |
NIBC Bank NV
NIBC Bank NV Finance/Rental/LeasingFinance NIBC Bank NV engages in the provision of investment banking and financial services. The firm offers advises on mergers, acquisitions, financial policy, and property financing, lending, leveraged finance, and derivatives. It provides asset financing to corporate lending, leveraged finance, oil and gas services, infrastructure, real estate, and shipping Sector. The company was founded in 1945 and is headquartered in The Hague, the Netherlands. | Finance/Rental/Leasing | Corporate Officer/Principal | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Founder | |
ALK-ABELLÓ A/S | Biotechnology | Corporate Officer/Principal | |
University of Groningen | College/University | Graduate Degree | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Corporate Officer/Principal | |
NV Limburgs Instituut voor Ontwikkeling en Financiering
NV Limburgs Instituut voor Ontwikkeling en Financiering Investment ManagersFinance NV Limburgs Instituut voor Ontwikkeling en Financiering (LIOF) is a private equity & venture capital firm, a subsidiary of Government of the Netherlands founded in 1935. NV Limburgs Instituut voor Ontwikkeling en Financiering is headquartered in Maastricht, the Neterlands. | Investment Managers | Private Equity Investor | |
FABPulous BV
FABPulous BV Medical SpecialtiesHealth Technology FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Director/Board Member | |
Brightlands Venture Partners BV
Brightlands Venture Partners BV Investment ManagersFinance Brightlands Venture Partners is an independent regional venture capital firm headquartered in Brightlands, Netherlands. The firm was founded in 2004. | Investment Managers | Private Equity Investor | |
Triodos Investment Management BV
Triodos Investment Management BV Investment ManagersFinance Triodos Investment Management BV (Triodos Investment Management) is a private equity/venture capital firm subsidiary of Triodos Bank NV founded in 1980. The firm is headquartered is headquartered in Zeist, Netherlands. | Investment Managers | Chief Investment Officer | |
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Investment Banks/Brokers | Analyst-Equity | |
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Chief Operating Officer |
Statistics
International
Netherlands | 25 |
Denmark | 15 |
Sweden | 8 |
Belgium | 3 |
France | 2 |
Sectoral
Health Technology | 19 |
Finance | 16 |
Consumer Services | 7 |
Technology Services | 3 |
Retail Trade | 3 |
Operational
Private Equity Investor | 47 |
Private Equity Analyst | 17 |
Director/Board Member | 14 |
Corporate Officer/Principal | 13 |
Chief Tech/Sci/R&D Officer | 8 |
Most connected contacts
- Stock Market
- Insiders
- Mariëtte van der Velden-Roesink
- Company connections